疏血通及依达拉奉联合应用对老年脑梗死患者的临床效果分析  

Analysis of the Effect of Shuxuetong and Edaravone in Elderly Patients With Cerebral Infarction

作　　者：汪萍[1] 方明[1] 付楠良[1] 宋承伟[1] 

机构地区：[1]三峡大学人民医院神经内科,湖北宜昌443000

出　　处：《中国卫生标准管理》2016年第6期129-130,共2页China Health Standard Management

摘　　要：目的探讨联合应用疏血通、依达拉奉对老年脑梗死(CI)的临床疗效。方法选择我院90例老年CI患者,按照用药方案不同将其分为两组,即观察组45例,联合应用疏血通及依达拉奉治疗,对照组45例,应用依达拉奉单药治疗;比较两组治疗效果。结果 1个疗程后,观察组脑卒中量表(NIHSS)评分及日常生活能力(ADL)评分均优于对照组(P<0.05)。观察组治疗总有效率95.56%,高于对照组80.00%(P<0.05)。结论联合应用疏血通、依达拉奉治疗老年CI可有效改善患者临床症状,提高患者生活能力。Objective To study the effect of Shuxuetong and edaravone in elderly patients with cerebral infarction（CI）. Methods 90 cases of patients with CI were randomly divided into the observation group 45 cases,used Shu Xiexuetong and edaravone,the control group 45 cases used edaravone single.The therapeutic effect of two groups were compared. Results After 1 course of treatment,the NIHSS and ADL scores of the observation group were better than the control group（P〈0.05）. The total effective rate of the observation group was 95.56%,which was significantly higher than control group 80.00%（P〈0.05）. Conclusion Application of Shuxuetong and edaravone in treatment of patients with CI can effectively improve the clinical symptoms, improve the ability of life.

关 键 词：脑梗死 疏血通 依达拉奉 

分 类 号：R743[医药卫生—神经病学与精神病学]